Capital increase strengthens ADL’s position

Capital increase strengthens ADL’s position

ADL BioPharma increases capital by EUR 24 million, which is 100% subscribed by Kartesia as the sole shareholder, by converting an equivalent amount of all its old loans in the company. In this way, ADL significantly reduces its debt ratios and financial interest...
ADL BioPharma participates in “Expo León i4.0” fair

ADL BioPharma participates in “Expo León i4.0” fair

In ADL BioPharma we continue to strengthen ties with the University of Leon and betting on local talent. On May 20, we were present at the “Expo León i4.0” fair, which brought together about thirty companies from the technological and industrial sector of...